AI can predict brain cancer patients' survival

byKing's College LondonCredit: CC0 Public DomainNew research shows that artificial intelligence (AI) can predict whether adult patients with brain cancer will survive more than eight months

Updated on: March 05,2024

AI can predict brain cancer patients' survival

byKing's College LondonCredit: CC0 Public DomainNew research shows that artificial intelligence (AI) can predict whether adult patients with brain cancer will survive more than eight months

Updated on:March 05,2024

Researchers identify cell signaling pathways controlling melanoma cell metastasis to the brain

by H. Lee Moffitt Cancer Center & Research InstituteHDAC8 increases the establishment of melanoma brain metastases.a–cHDAC8 and EV expressing WM164 cells were introduced into NOD.

Updated on: June 22,2024

Researchers identify cell signaling pathways controlling melanoma cell metastasis to the brain

by H. Lee Moffitt Cancer Center & Research InstituteHDAC8 increases the establishment of melanoma brain metastases.a–cHDAC8 and EV expressing WM164 cells were introduced into NOD.

Updated on:June 22,2024

Deep learning approach enhances HER2 scoring in breast cancer

byUCLA Engineering Institute for Technology AdvancementAutomated HER2 Scoring in Breast Cancer Images Using Deep Learning and Pyramid Sampling. Credit: UCLA Engineering Institute for Technology

Updated on: August 01,2024

Deep learning approach enhances HER2 scoring in breast cancer

byUCLA Engineering Institute for Technology AdvancementAutomated HER2 Scoring in Breast Cancer Images Using Deep Learning and Pyramid Sampling. Credit: UCLA Engineering Institute for Technology

Updated on:August 01,2024

Tumor matrix profiling gives clues to progression of some lung cancers

byGarvan Institute of Medical ResearchGraphic of lungs and cells. Credit: Thomas Cox/Garvan InstituteScientists at the Garvan Institute of Medical Research have identified molecular profiles of

Updated on: January 22,2024

Tumor matrix profiling gives clues to progression of some lung cancers

byGarvan Institute of Medical ResearchGraphic of lungs and cells. Credit: Thomas Cox/Garvan InstituteScientists at the Garvan Institute of Medical Research have identified molecular profiles of

Updated on:January 22,2024

ASCO: Pembrolizumab superior for initial Tx of advanced NSCLC

(HealthDay)—For patients with programmed death ligand 1 (PD-L1)-expressing locally advanced or metastatic non-small-cell lung cancer (NSCLC), pembrolizumab is associated with better overall survival t

Updated on: March 30,2024

ASCO: Pembrolizumab superior for initial Tx of advanced NSCLC

(HealthDay)—For patients with programmed death ligand 1 (PD-L1)-expressing locally advanced or metastatic non-small-cell lung cancer (NSCLC), pembrolizumab is associated with better overall survival t

Updated on:March 30,2024

Discovery paves way for precision medicine in future

by University of OtagoThis high-dimensional analysis reveals the T cell signature in people with bowel cancer. The new analysis groups cells together so all cells can be viewed at once. In the pa

Updated on: April 18,2024

Discovery paves way for precision medicine in future

by University of OtagoThis high-dimensional analysis reveals the T cell signature in people with bowel cancer. The new analysis groups cells together so all cells can be viewed at once. In the pa

Updated on:April 18,2024

Mouse studies have revealed more about the mechanisms behind cancer drugs in trials

by Agency for Science, Technology and Research (A*STAR), SingaporeDNA damage (red) in the spleen of a mouse that expresses the mutant form of CDK1 that cannot be suppressed by phosphorylation. Cr

Updated on: March 01,2024

Mouse studies have revealed more about the mechanisms behind cancer drugs in trials

by Agency for Science, Technology and Research (A*STAR), SingaporeDNA damage (red) in the spleen of a mouse that expresses the mutant form of CDK1 that cannot be suppressed by phosphorylation. Cr

Updated on:March 01,2024

Virus-targeting white blood cells in tumors offer intriguing insights into responsiveness to immunotherapy

by Agency for Science, Technology and Research (A*STAR), SingaporeGreen and red tumor-infiltrating lymphocytes expressing CD39 in human lung cancer. Credit: A*STAR Singapore Immunology NetworkBys

Updated on: March 06,2024

Virus-targeting white blood cells in tumors offer intriguing insights into responsiveness to immunotherapy

by Agency for Science, Technology and Research (A*STAR), SingaporeGreen and red tumor-infiltrating lymphocytes expressing CD39 in human lung cancer. Credit: A*STAR Singapore Immunology NetworkBys

Updated on:March 06,2024

Revealing characteristics of circulating cell-free RNA in the blood of liver cancer patients

byScience China PressMOF materials efficiently enrich circulating nucleic acids (cfDNA and cfRNA) in blood through a simple operational process, enabling various downstream nucleic acid detectio

Updated on: March 30,2024

Revealing characteristics of circulating cell-free RNA in the blood of liver cancer patients

byScience China PressMOF materials efficiently enrich circulating nucleic acids (cfDNA and cfRNA) in blood through a simple operational process, enabling various downstream nucleic acid detectio

Updated on:March 30,2024

Researchers discover molecule that promotes production of cancer cells in triple-negative breast cancer

byHiroshima UniversityHiroshima University researchers found that AIbZIP is highly upregulated in triple negative breast cancer (TNBC). AIbZIP induces hyper proliferation of TNBC cells by promot

Updated on: March 30,2024

Researchers discover molecule that promotes production of cancer cells in triple-negative breast cancer

byHiroshima UniversityHiroshima University researchers found that AIbZIP is highly upregulated in triple negative breast cancer (TNBC). AIbZIP induces hyper proliferation of TNBC cells by promot

Updated on:March 30,2024

First randomized phase 3 clinical trial of neoadjuvant immunotherapy in patients with kidney cancer

by ECOG-ACRIN Cancer Research GroupCredit: Pixabay/CC0 Public DomainThe ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) will present data from PROSPER RCC (EA8143), the first randomized phase 3 trial of

Updated on: January 04,2024

First randomized phase 3 clinical trial of neoadjuvant immunotherapy in patients with kidney cancer

by ECOG-ACRIN Cancer Research GroupCredit: Pixabay/CC0 Public DomainThe ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) will present data from PROSPER RCC (EA8143), the first randomized phase 3 trial of

Updated on:January 04,2024

Researchers discover how to predict the efficacy of one of the most widely used drugs against breast cancer

by The Spanish National Cancer Research CentreClinical trial tumor samples: the phosphoprofiles were independent of the study site and/or treatment arm.AClinical trial treatment and s

Updated on: February 18,2024

Researchers discover how to predict the efficacy of one of the most widely used drugs against breast cancer

by The Spanish National Cancer Research CentreClinical trial tumor samples: the phosphoprofiles were independent of the study site and/or treatment arm.AClinical trial treatment and s

Updated on:February 18,2024